Document:

Exhibit 4.3

NEITHER THIS WARRANT NOR THE  SECURITIES  INTO WHICH THIS WARRANT IS EXERCISABLE
HAVE  BEEN  REGISTERED  WITH  THE  SECURITIES  AND  EXCHANGE  COMMISSION  OR THE
SECURITIES   COMMISSION  OF  ANY  STATE  IN  RELIANCE  UPON  AN  EXEMPTION  FROM
REGISTRATION  UNDER THE  SECURITIES  ACT OF 1933,  AS AMENDED  (THE  "SECURITIES
ACT"),  AND,  ACCORDINGLY,  MAY NOT BE OFFERED  OR SOLD  EXCEPT  PURSUANT  TO AN
EFFECTIVE  REGISTRATION  STATEMENT  UNDER THE  SECURITIES  ACT OR PURSUANT TO AN
AVAILABLE  EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE  REGISTRATION
REQUIREMENTS  OF THE  SECURITIES  ACT AND IN ACCORDANCE  WITH  APPLICABLE  STATE
SECURITIES  LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH  EFFECT,  THE  SUBSTANCE  OF WHICH SHALL BE  REASONABLY  ACCEPTABLE  TO THE
COMPANY.  THESE  SECURITIES AND THE  SECURITIES  ISSUABLE UPON EXERCISE OF THESE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.

Right  to   Purchase   [______________]   shares  of   Common   Stock  of  CHINA
BIOPHARMACEUTICALS HOLDINGS, INC. (subject to adjustment as provided herein)

                          COMMON STOCK PURCHASE WARRANT

No. [ ]-[#] Issue Date:[__________, 2006

      CHINA BIOPHARMACEUTICALS HOLDINGS, INC., a corporation organized under the
laws of the State of Delaware (the "Company"),  hereby certifies that, for value
received, [ ] or its assigns (the "Holder"),  is entitled,  subject to the terms
set forth below,  to purchase from the Company at any time and from time to time
from and after the Issue Date and through and including  [__________,  2010 (the
"Expiration Date"), up to a total of [ ] fully paid and nonassessable  shares of
the common stock of the Company (the "Common  Stock"),  $.01 par value per share
at a per share purchase price of $1.26 in lawful money of the United States. The
aforedescribed purchase price per share, as adjusted from time to time as herein
provided,  is  referred  to herein  as the  "Exercise  Price."  The  number  and
character of such shares of Common  Stock and the Exercise  Price are subject to
adjustment as provided herein.  Capitalized terms used and not otherwise defined
herein shall have the meanings set forth in that certain Purchase Agreement (the
"Purchase Agreement"),  dated [_________,  2006, entered into by the Company and
the Holder.

      As used herein the following terms, unless the context otherwise requires,
have the following respective meanings:

<PAGE>

         The term  "Company"  shall include China  Biopharmaceuticals  Holdings,
Inc. and any corporation  which shall succeed or assume the obligations of China
Biopharmaceuticals Holdings, Inc. hereunder.

         The term "Common Stock" includes (a) the Company's Common Stock,  $.001
par value per share,  as authorized on the date of the Purchase  Agreement,  and
(b) any other securities into which or for which any of the securities described
in (a) may be  converted or  exchanged  pursuant to a plan of  recapitalization,
reorganization, merger, sale of assets or otherwise.

         The term "Fundamental  Transaction" means any of the following: (1) the
Company effects any merger or  consolidation of the Company with or into another
Person,  (2) the  Company  effects any sale of all or  substantially  all of its
assets in one or a series  of  related  transactions,  (3) any  tender  offer or
exchange offer (whether by the Company or another Person) is completed  pursuant
to which  holders of Common  Stock are  permitted  to tender or  exchange  their
shares for other  securities,  cash or property,  or (4) the Company effects any
reclassification  of the Common Stock or any compulsory share exchange  pursuant
to which the Common Stock is  effectively  converted into or exchanged for other
securities, cash or property.

         The term "Issue Date" means the Issue Date first set forth on the first
page of this Warrant.

         1. Exercise.

                  (a) To effect  exercises  hereunder,  the Holder  shall not be
required to  physically  surrender  this Warrant  unless the  aggregate  Warrant
Shares represented by this Warrant is being exercised. Upon delivery of the form
of subscription  attached hereto (the "Subscription Form") to the Company at its
address for notice set forth in the Purchase  Agreement  and upon payment of the
Exercise  Price  multiplied  by the  number of  Warrant  Shares  that the Holder
intends to purchase hereunder, the Company shall promptly (but in no event later
than three  Trading Days after the Date of Exercise (as defined  herein))  issue
and deliver to the Holder,  a certificate  for the Warrant Shares  issuable upon
such exercise, which, unless otherwise required by the Purchase Agreement, shall
be free of restrictive legends. A "Date of Exercise" means the date on which the
Holder  shall  have  delivered  to  the  Company:  (i)  the  Subscription  Form,
appropriately  completed and duly signed and (ii) payment of the Exercise  Price
for the number of Warrant Shares so indicated by the Holder to be purchased.

                  (b) If by the third  Trading Day after a Date of Exercise  the
Company  fails to deliver the  required  number of Warrant  Shares in the manner
required  pursuant  to  Section  1(a),  then the  Holder  will have the right to
rescind such exercise.

                  (c) If by the third  Trading Day after a Date of Exercise  the
Company  fails to deliver the  required  number of Warrant  Shares in the manner
required pursuant to Section 1(a), and if after such third Trading Day and prior
to the receipt of such Warrant Shares,  the Holder  purchases (in an open market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a

                                       2
<PAGE>

sale by the Holder of the Warrant Shares which the Holder anticipated  receiving
upon such exercise (a  "Buy-In"),  then the Company shall (1) pay in cash to the
Holder the amount by which (x) the  Holder's  total  purchase  price  (including
brokerage  commissions,  if any) for the  shares  of Common  Stock so  purchased
exceeds (y) the amount  obtained by multiplying (A) the number of Warrant Shares
that the Company was  required to deliver to the Holder in  connection  with the
exercise at issue by (B) the  closing bid price of the Common  Stock on the Date
of Exercise and (2) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent  number of Warrant Shares for which such exercise was
not  honored or deliver to the Holder the number of shares of Common  Stock that
would have been issued had the Company  timely  complied  with its  exercise and
delivery  obligations  hereunder.  The Holder shall provide the Company  written
notice indicating the amounts payable to the Holder in respect of the Buy-In.

                  (d) The  Company's  obligations  to issue and deliver  Warrant
Shares in  accordance  with the terms  hereof are  absolute  and  unconditional,
irrespective  of any action or inaction  by the Holder to enforce the same,  any
waiver or consent  with  respect to any  provision  hereof,  the recovery of any
judgment  against any Person or any action to enforce  the same,  or any setoff,
counterclaim,  recoupment,  limitation or termination,  or any breach or alleged
breach by the Holder or any other Person of any obligation to the Company or any
violation  or alleged  violation of law by the Holder or any other  Person,  and
irrespective  of  any  other  circumstance  which  might  otherwise  limit  such
obligation  of the  Company to the Holder in  connection  with the  issuance  of
Warrant Shares.  Nothing herein shall limit a Holder's right to pursue any other
remedies  available  to it  hereunder,  at law or in equity  including,  without
limitation,  a decree of  specific  performance  and/or  injunctive  relief with
respect to the Company's  failure to timely  deliver  certificates  representing
Warrant  Shares upon  exercise of the Warrant as required  pursuant to the terms
hereof.

         2. Certain Adjustments. The Exercise Price and number of Warrant Shares
issuable upon  exercise of this Warrant are subject to  adjustment  from time to
time as set forth in this Section 2.

                  (a) Stock  Dividends and Splits.  If the Company,  at any time
while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock
or otherwise  makes a distribution on any class of capital stock that is payable
in shares of Common Stock,  (ii) subdivides  outstanding  shares of Common Stock
into a larger number of shares, or (iii) combines  outstanding  shares of Common
Stock into a smaller number of shares, then in each such case the Exercise Price
shall be multiplied by a fraction of which the numerator  shall be the number of
shares of Common Stock  outstanding  immediately  before such event and of which
the  denominator  shall be the  number of shares  of  Common  Stock  outstanding
immediately after such event. Any adjustment made pursuant to clause (i) of this
paragraph  shall  become  effective  immediately  after the record  date for the
determination of stockholders entitled to receive such dividend or distribution,
and any  adjustment  pursuant  to clause (ii) or (iii) of this  paragraph  shall
become  effective  immediately  after the effective date of such  subdivision or
combination.

                                       3
<PAGE>

                  (b)  Fundamental  Transactions.  If,  at any time  while  this
Warrant is outstanding there is a Fundamental Transaction, then the Holder shall
have the right  thereafter to receive,  upon exercise of this Warrant,  the same
amount and kind of  securities,  cash or property as it would have been entitled
to receive upon the occurrence of such  Fundamental  Transaction if it had been,
immediately prior to such Fundamental  Transaction,  the holder of the number of
Warrant  Shares  then  issuable  upon  exercise  in full of  this  Warrant  (the
"Alternate Consideration"). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such  Fundamental  Transaction,  and the Company
shall  apportion  the  Exercise  Price among the  Alternate  Consideration  in a
reasonable manner  reflecting the relative value of any different  components of
the Alternate Consideration.  If holders of Common Stock are given any choice as
to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration
it  receives  upon any  exercise  of this  Warrant  following  such  Fundamental
Transaction. At the Holder's option and request, any successor to the Company or
surviving entity in such Fundamental  Transaction shall, either (1) issue to the
Holder a new warrant  substantially  in the form of this Warrant and  consistent
with the foregoing  provisions and evidencing the Holder's right to purchase the
Alternate  Consideration for the aggregate Exercise Price upon exercise thereof,
or (2)  purchase the Warrant  from the Holder for a purchase  price,  payable in
cash within five Trading Days after such request (or, if later, on the effective
date of the  Fundamental  Transaction),  equal to the Black Scholes value of the
remaining  unexercised portion of this Warrant on the date of such request.  The
terms of any agreement  pursuant to which a Fundamental  Transaction is effected
shall include terms  requiring any such successor or surviving  entity to comply
with the  provisions of this paragraph (b) and insuring that the Warrant (or any
such  replacement  security)  will be  similarly  adjusted  upon any  subsequent
transaction analogous to a Fundamental Transaction.

                  (c)  Number  of  Warrant  Shares.   Simultaneously   with  any
adjustment  to the  Exercise  Price  pursuant  to this  Section 2, the number of
Warrant  Shares that may be purchased  upon  exercise of this  Warrant  shall be
increased  or  decreased  proportionately,  so that  after such  adjustment  the
aggregate  Exercise Price payable  hereunder for the adjusted  number of Warrant
Shares shall be the same as the aggregate  Exercise Price in effect  immediately
prior to such adjustment.

                  (d)  Notice  of  Adjustments.  Upon  the  occurrence  of  each
adjustment  pursuant to this Section 2, the Company at its expense will promptly
compute such adjustment in accordance with the terms of this Warrant and prepare
a  certificate  setting  forth such  adjustment,  including a  statement  of the
adjusted  Exercise Price and adjusted  number or type of Warrant Shares or other
securities  issuable upon exercise of this Warrant (as  applicable),  describing
the transactions giving rise to such adjustments and showing in detail the facts
upon which such  adjustment  is based.  Upon written  request,  the Company will
promptly  deliver  a copy of each  such  certificate  to the  Holder  and to the
Company's Transfer Agent.

                                       4
<PAGE>

                  (e) Notice of Corporate  Events. If the Company (i) declares a
dividend or any other  distribution  of cash,  securities  or other  property in
respect of its Common Stock, including without limitation any granting of rights
or warrants to subscribe for or purchase any capital stock of the Company or any
Subsidiary, (ii) authorizes or approves, enters into any agreement contemplating
or  solicits  stockholder  approval  for any  Fundamental  Transaction  or (iii)
authorizes the voluntary  dissolution,  liquidation or winding up of the affairs
of the Company, then the Company shall deliver to the Holder a notice describing
the material  terms and conditions of such  transaction  (but only to the extent
such disclosure would not result in the  dissemination  of material,  non-public
information  to the  Holder) at least 10 calendar  days prior to the  applicable
record or  effective  date on which a Person  would need to hold Common Stock in
order to  participate  in or vote  with  respect  to such  transaction,  and the
Company  will take all steps  reasonably  necessary  in order to insure that the
Holder is given the practical opportunity to exercise this Warrant prior to such
time so as to participate in or vote with respect to such transaction; provided,
however, that the failure to deliver such notice or any defect therein shall not
affect the  validity of the  corporate  action  required to be described in such
notice.

         3.  Limitations on Exercise.  Notwithstanding  anything to the contrary
contained  herein,  the number of Warrant  Shares  that may be  acquired  by the
Holder upon any exercise of this Warrant (or otherwise in respect  hereof) shall
be limited to the extent  necessary to insure that,  following such exercise (or
other  issuance),  the total number of shares of Common Stock then  beneficially
owned by such Holder and its Affiliates  and any other Persons whose  beneficial
ownership of Common Stock would be aggregated  with the Holder's for purposes of
Section 13(d) of the Exchange Act, does not exceed 9.999% of the total number of
issued and  outstanding  shares of Common Stock  (including for such purpose the
shares  of  Common  Stock  issuable  upon  such  exercise).  For such  purposes,
beneficial ownership shall be determined in accordance with Section 13(d) of the
Exchange  Act  and  the  rules  and  regulations  promulgated  thereunder.  This
provision shall not restrict the number of shares of Common Stock which a Holder
may receive or  beneficially  own in order to determine the amount of securities
or  other  consideration  that  such  Holder  may  receive  in  the  event  of a
Fundamental  Transaction  as  contemplated  in Section 2 of this  Warrant.  This
restriction may not be waived, and  notwithstanding  anything to the contrary in
any Transaction Document, may not be amended by agreement of the parties.

         4. Common Stock  Legend.  The Holder  acknowledges  and agrees that the
shares of Common Stock of the Company,  and, until such time as the Common Stock
has been registered  under the 1933 Act and sold in accordance with an effective
registration statement,  or exemption from registration,  certificates and other
instruments representing any of the Common Stock shall bear a restrictive legend
in  substantially  the following  form and a  stop-transfer  order may be placed
against transfer of any such securities:

                  THE  SHARES  REPRESENTED  BY THIS  CERTIFICATE  HAVE  NOT BEEN
REGISTERED  WITH THE  SECURITIES  AND  EXCHANGE  COMMISSION  NOR THE  SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION  FROM  REGISTRATION  UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY,

                                       5
<PAGE>

MAY  NOT BE  OFFERED  OR  SOLD  EXCEPT  PURSUANT  TO AN  EFFECTIVE  REGISTRATION
STATEMENT  UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE  EXEMPTION FROM,
OR IN A  TRANSACTION  NOT  SUBJECT  TO,  THE  REGISTRATION  REQUIREMENTS  OF THE
SECURITIES  ACT AND IN  ACCORDANCE  WITH  APPLICABLE  STATE  SECURITIES  LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE  TRANSFEROR  TO SUCH EFFECT,  THE
SUBSTANCE OF WHICH SHALL BE REASONABLY  ACCEPTABLE TO THE COMPANY.  THESE SHARES
MAY BE  PLEDGED  IN  CONNECTION  WITH A BONA FIDE  MARGIN  ACCOUNT OR OTHER LOAN
SECURED BY SUCH SHARES.

         5. Warrant  Agent.  The Company may, by written notice to the Holder of
the  Warrant,  appoint an agent (a  "Warrant  Agent") for the purpose of issuing
Common Stock issuable on the exercise of this Warrant.

         6. Miscellaneous. The Warrant Shares shall be accorded the registration
rights set forth in the Registration Rights Agreement.

                  This  Warrant  and any term  hereof  may be  changed,  waived,
discharged  or terminated  only by an instrument in writing  signed by the party
against which  enforcement of such change,  waiver,  discharge or termination is
sought.  This Warrant  shall be construed  and enforced in  accordance  with and
governed  by the laws of the State of New  York,  without  giving  effect to the
conflicts of laws principles thereof.

                  This Warrant and the legal  relations among the parties hereto
shall be governed by and  construed  in  accordance  with the laws of the United
States  of  America  and State of New York,  regardless  of the laws that  might
otherwise govern under applicable choice-of-law  principles.  The parties hereby
irrevocably  submit to the  non-exclusive  jurisdiction of the state and federal
courts  located  in the State and County of New York for  purposes  of all legal
proceedings  arising out of or relating to this Common Stock Purchase Warrant or
the transactions  contemplated  hereby. The parties hereby irrevocably waive, to
the fullest extent  permitted by applicable law, the right to trial by jury, any
objection  which  they may now or  hereafter  have to the laying of venue of any
such  proceeding  brought in such a court and any claim that any such proceeding
brought in such a court has been brought in an inconvenient forum.

                      [THE NEXT PAGE IS THE SIGNATURE PAGE]

                                       6
<PAGE>

         IN WITNESS  WHEREOF,  the Company has  executed  this Warrant as of the
date first written above.

                                  China Biopharmaceuticals Holdings, Inc.

                                  By:
                                     ___________________________________________
                                     Name: Chris Peng Mao

                                     Title: Chief Executive Officer and Chairman

                                       7
<PAGE>

                                    Exhibit A

                              FORM OF SUBSCRIPTION

                   (to be signed only on exercise of Warrant)

TO:  CHINA BIOPHARMACEUTICALS HOLDINGS INC.

The  undersigned,  pursuant to the provisions set forth in the attached  Warrant
(No.[ ]-[#]), hereby irrevocably elects to purchase:

_____ Shares of the Common Stock covered by such Warrant.

The  undersigned  herewith  makes  payment of the full  purchase  price for such
shares at the price per share provided for in such Warrant, which is $1.26. Such
payment takes the form of:

$________ in lawful money of the United States.

The undersigned  requests that the certificates for such shares be issued in the
name of, and delivered to _____________________________________ whose address is
_______________________________________________________________________________.

By its  delivery of this  Subscription  Form,  the  undersigned  represents  and
warrants to the Company that in giving effect to the exercise  evidenced  hereby
the Holder will not beneficially own in excess of the number of shares of Common
Stock  (determined in accordance  with Section 13(d) of the Securities  Exchange
Act of 1934) permitted to be owned under Section 3 of this Warrant to which this
notice relates.

Dated:

                                    (Address)Exhibit 10.13

    EXHIBIT 10.13

     

     

    TIB
      FINANCIAL CORP.

    RESTRICTED
      STOCK AGREEMENT

    

    

    THIS
      RESTRICTED STOCK AGREEMENT, dated _____________, 2005, is between TIB Financial
      Corp., a Florida corporation (the “Company”),
      and
      _________________________ (the “Holder”).

    

    1. Recitals.
      The
      Holder is being awarded _______ shares of the $.10 par value common stock of
      TIB
      Financial Corp. (the “Restricted
      Shares”
or
      “Shares”)
      pursuant to the TIB Financial Corp. 2004 Equity Incentive Plan (“Plan”).
      All
      terms which are defined in the Plan, as the same may be amended from time to
      time, shall have the same meanings in this Agreement as are specified in the
      Plan, unless otherwise specifically defined herein.

    

    2. Restrictions.
      The
      Holder shall not sell, assign, transfer by gift or otherwise, pledge, encumber,
      hypothecate, or otherwise dispose of, by operation of law or otherwise, any
      of
      the Restricted Shares unless and to the extent the Restricted Shares have become
      Vested Shares as provided below.

    

    3. Vesting;
      Lapse of Restrictions.

    

    (a) General.
      Except
      as otherwise provided in this Agreement, the Restricted Shares shall vest and
      the restrictions shall lapse on the date set forth in Exhibit A to this
      Agreement (the “Vesting
      Date”),
      provided that the Holder shall not have ceased Continuous Service before the
      Vesting Date. Restricted Shares that have become vested and as to which the
      restrictions have lapsed shall be referred to as “Vested
      Shares”;
      Restricted Shares that have not become vested and as to which the restrictions
      have not lapsed shall be referred to as “Unvested
      Shares.”
      Subject to Section 5 of this Agreement, the Holder will have all the rights
      of a
      shareholder with respect to the Restricted Shares, including, but not limited
      to, the right to receive all dividends paid on the Restricted Shares and the
      right to vote the Restricted Shares.

    

    (b) Vesting
      on Certain Events.
      All
      Unvested Shares shall immediately vest and be considered Vested Shares upon
      a
      Change of Control or the death of the Holder. 

    

    (c) Transfer
      Upon Lapse of Restrictions.
      The
      Holder may sell, assign, transfer by gift or otherwise, hypothecate, or
      otherwise dispose of, by operation of law or otherwise, any of the Vested Shares
      at the Holder’s discretion, except that the Holder agrees that he shall not make
      any sale or transfer of the Vested Shares that would conflict with or violate
      any of the provisions of the Securities Act of 1933 or any applicable state
      securities laws.

    

    4. Termination
      of Services. Subject
      to Section 3(b), if the Holder ceases Continuous Services for any reason before
      the Unvested Shares have vested, the Holder’s rights with respect to the
      Unvested Shares will terminate and be returned to the Company. The Holder
shall
      execute such documents and take such other actions as may be necessary in order
      to transfer full legal title with respect to such Unvested Shares to the
      Company. 

    

    5. Delivery
      of Unvested Shares.
      If the
      Holder or the Holder’s representative is required to transfer certain of the
      Shares to the Company pursuant to Section 4, the Shares shall promptly be
      tendered to the Company by the delivery of certificates for such Shares, duly
      endorsed in blank by the Holder or the Holder’s representative or with stock
      powers attached thereto duly endorsed, at the Company’s principal offices, all
      in form suitable for the transfer of such Shares to the Company. The Company
      shall not pay any dividend to the Holder on account of such Shares or permit
      the
      Holder to exercise any of the privileges or rights of a stockholder with respect
      to such Shares, but shall, in so far as permitted by law, treat the Company
      as
      the owner of such Shares.

    

    6. Effect
      of Prohibited Transfer.
      The
      Company may refuse for any purpose to recognize any transferee who receives
      Shares contrary to the provisions of this Agreement as a stockholder of the
      Company and may retain and/or recover all dividends on such Restricted Shares
      that were paid or payable subsequent to the date on which the prohibited
      transfer was made or attempted. In addition to any other legal or equitable
      remedies it may have, the Company may enforce its rights to specific performance
      to the extent permitted by law and may exercise such other equitable remedies
      then available to it. 

    

    7. Enforcement
      of Restrictions

    

    (a) Legend.
      All
      certificates representing Restricted Shares shall have affixed thereto the
      following legend:

    

    “The
      shares of stock represented by this Certificate are subject to all of the terms
      of a Restricted Stock Repurchase Agreement between TIB Financial Corp. and
      the
      registered owner of this Certificate (the “Agreement”). Copies of the Agreement
      and the Plan are on file at the office of the Company. The Agreement, among
      other things, limits the right of the holder to transfer the shares represented
      hereby and provides in certain circumstances that all or a portion of the shares
      must be returned to the Company.”

    

    (b) Custody
      of Certificates.
      The
      Company may, in its sole discretion, require the Holder to keep the certificate
      representing the Restricted Shares, duly endorsed, in the custody of the Company
      while the Shares are subject to the restrictions contained in Section 2. The
      Company may, in its sole discretion, require that the certificate representing
      the Shares, duly endorsed, be held in the custody of a third party while the
      Shares are subject to the restrictions contained in Section 2.

     

    (c) Lapse
      of Restrictions.
      At the
      expiration of the restrictions imposed by this Agreement, the Company will
      redeliver to the Holder the certificate or certificates and stock powers,
      deposited with the Company pursuant to this Agreement and the Shares represented
      by the certificate or certificates will be free of all
      restrictions.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    8. Adjustments
      for Stock Splits, Stock Dividends, etc.
      In the
      event of any change in the outstanding Stock hereafter by reason of any
      reorganization, recapitalization, stock split, stock dividend, a combination
      or
      exchange of shares, merger, consolidation or any change in the corporate
      structure affecting the Stock, the Shares shall be proportionately and
      appropriately adjusted by the Board pursuant to the provisions of the Plan.
      Any
      such additional Shares shall be subject to the restrictions and other provisions
      of this Agreement in the same manner and to the same extent as the Restricted
      Stock. All certificates representing such additional Shares of capital stock
      shall have affixed thereto the restrictive legends contained in Sections 7
      and 9 hereof. If the Company shall at any time distribute with respect to the
      Stock assets or securities of persons other than the Company (other than
      distributions of cash or Stock), if the Company shall at any time grant to
      the
      holders of its Stock rights to subscribe pro
      rata
      for
      additional shares thereof or for any other securities of the Company or of
      any
      other corporation, or if there is any other change in the number or kind of
      outstanding Stock or any stock or other securities into which the Stock shall
      be
      changed or for which it shall have been exchanged, and if the Company shall
      in
      its discretion determine that the event equitably requires an adjustment in
      the
      number or kind of Shares subject to this Agreement or the taking of any other
      action by the Company, including without limitation the setting aside of any
      property for delivery upon the full vesting of the Shares subject to this
      Agreement, then such adjustments shall be made or other action taken by the
      Company and shall be effective for all purposes of this Agreement. 

     

    9. Investment
      Representations.
      If
      requested by the Company, the Holder shall provide the Company with a written
      representation to the effect that the Shares are being acquired solely for
      investment and not with a view to, or for sale in connection with, any
      distribution of the Shares in any manner that would violate federal or state
      securities laws. The Holder acknowledges that all certificates representing
      Shares may have affixed thereto a restrictive legend to evidence the requirement
      for compliance with the Securities Act of 1933 and any applicable state
      securities laws. If the Shares granted pursuant to this Agreement are not issued
      in a registered transaction, the following additional legend shall be printed
      on
      all certificates representing such Shares:

    

    The
      Shares represented by this Certificate are “restricted securities” as defined in
      Rule 144 under the Securities Act of 1933 and may not be sold or transferred
      except in transactions which comply with Rule 144 or, in the opinion of counsel
      acceptable to TIB Financial Corp., are exempt therefrom.

    

    10. General. 

    

    (a)
       Continuous
      Service.
      Nothing
      in this Agreement shall confer upon Holder the right to continue in the
      Continuous Service of the Company or its subsidiaries.

    

    (b) Other
      Compensation Plans.
      The
      adoption of the Plan and the execution of this Agreement shall not affect any
      other stock option or incentive or other compensation plans in effect for the
      Company or its subsidiaries, nor shall the Plan or this Agreement preclude
      the
      Company or the Bank from establishing any other forms of incentive or other
      compensation for directors, officers, or employees of the Company and/or its
      Subsidiaries.

    

    (c) Agreement
      Binding on Successors.
      This
      Agreement shall be binding upon the successors and assigns of the Company and
      the Holder.

    

    (d) Singular,
      Plural; Gender.
      Whenever used herein, nouns in the singular shall include the plural, and the
      masculine pronoun shall include the feminine gender.

    

    (e) Applicable
      Law.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Florida.

    

    (f) Headings.
      Headings of Articles and Sections hereof are inserted for convenience and
      reference only; they constitute no part of this Agreement.

    

    (g) Severability.
      If any
      provision or provisions of this Agreement shall be held to be invalid, illegal,
      or unenforceable, the validity, legality, and enforceability of the remaining
      provisions shall not in any way be affected or impaired thereby.

    

    (h) Notices.
      Unless
      otherwise specified herein, notices required or permitted to be given hereunder
      shall be in writing and shall be mailed by registered or certified mail, return
      receipt requested, to the principal office of the Company, Attention: Corporate
      Secretary (if notice is to the Company) and to the Holder at the Holder’s
      address set forth below (if notice is to the Holder), or to such other person
      or
      such other address as any such party may designate by like notice to the other
      party, and shall be deemed given as of the date and time received.

    

    (i) Counterparts.
      This
      Agreement may be executed in any number of counterparts, each of which, when
      so
      executed, shall be considered an original, and all of which together shall
      constitute one and the same instrument.

    

    (j) Subject
      to Plan.
      The
      issuance of the Option shall be subject to the terms and conditions of the
      Plan.
      In the event of any conflict between the terms of this Agreement and the Plan,
      the terms of the Plan shall govern.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
 

    

    IN
      WITNESS WHEREOF, the parties have executed this Agreement to be effective as
      set
      forth above.

    

    TIB
      FINANCIAL CORP.

    

    

    By:____________________________________

    

    

    HOLDER

    

    

    _______________________________________

    

    _______________________________________

    [PRINT
      NAME]

    

    

    

    

    
      
        
          

        

         

      

      
         

        
          

        

      

      
         

        
        

      

    

    EXHIBIT
      A TO RESTRICTED STOCK AGREEMENT

    

    The
      Restricted Shares shall vest and the restrictions shall lapse on ____________,
      200___ (which date may not be earlier than one year from the date of the
      Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]